Varying Doses of Buprenorphine for Opioid Dependence and Cocaine Abuse
Data Collection
Narcotic-Related Disorders+2
+ Mental Disorders
+ Opioid-Related Disorders
Treatment Study
Summary
Study start date: August 1, 1988
Actual date on which the first participant was enrolled.This study focuses on helping individuals who struggle with both opioid dependence and cocaine abuse. It aims to find out if different doses of a medication called buprenorphine can be effective in managing these conditions. Opioid dependence is a serious issue where a person feels they cannot function without using opioids, and this study hopes to provide a solution that could improve their quality of life. The research is important because it addresses the need for better treatment options for those battling both opioid dependence and cocaine abuse.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Please contact site for information.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
VA Connecticut Healthcare System
New Haven, United StatesOpen VA Connecticut Healthcare System in Google Maps